Psychemedics Stock Analysis

Psychemedics Stock Analysis Notes

About 23.0% of the company outstanding shares are owned by corporate insiders. The book value of Psychemedics was at this time reported as 1.15. The company recorded a loss per share of 0.51. Psychemedics last dividend was issued on the 24th of May 2023. The entity had 1:4 split on the 1st of August 2002. Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts. Psychemedics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1 people. To find out more about Psychemedics contact Raymond Kubacki at 800 527 7424 or learn more at https://www.psychemedics.com.

Psychemedics Investment Alerts

Psychemedics Upcoming and Recent Events

Psychemedics Largest EPS Surprises

View All Earnings Estimates

Psychemedics Environmental, Social, and Governance (ESG) Scores

Psychemedics Thematic Classifications

Psychemedics Stock Institutional Investors

Note, although Psychemedics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Psychemedics Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 15.74 M.

Psychemedics Profitablity

The company has Net Profit Margin of (0.22) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.19) %, which entails that for every $100 of revenue, it lost $0.19.

Management Efficiency

Psychemedics has Return on Asset of (0.1624) % which means that on every $100 spent on assets, it lost $0.1624. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.6133) %, meaning that it generated no profit with money invested by stockholders. Psychemedics' management efficiency ratios could be used to measure how well Psychemedics manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 20th of December, Psychemedics holds the Risk Adjusted Performance of 0.0629, coefficient of variation of 1457.34, and Semi Deviation of 3.35. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Psychemedics, as well as the relationship between them. Please check Psychemedics information ratio, and the relationship between the downside deviation and value at risk to decide if Psychemedics is priced some-what accurately, providing market reflects its current price of 2.67 per share. Please also confirm Psychemedics total risk alpha, which is currently at 0.2062 to check out the company can sustain itself at a future point.

Psychemedics Price Movement Analysis

Psychemedics Insider Trading Activities

Psychemedics Outstanding Bonds

Psychemedics Predictive Daily Indicators

Psychemedics Corporate Filings

Psychemedics Forecast Models

Psychemedics' time-series forecasting models are one of many Psychemedics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Psychemedics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Psychemedics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Psychemedics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Psychemedics. By using and applying Psychemedics Stock analysis, traders can create a robust methodology for identifying Psychemedics entry and exit points for their positions.

When running Psychemedics' price analysis, check to measure Psychemedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psychemedics is operating at the current time. Most of Psychemedics' value examination focuses on studying past and present price action to predict the probability of Psychemedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psychemedics' price. Additionally, you may evaluate how the addition of Psychemedics to your portfolios can decrease your overall portfolio volatility.